-
1 Comment
Biofil Chemicals and Pharmaceuticals Limited is currently in a long term downtrend where the price is trading 39.5% below its 200 day moving average.
From a valuation standpoint, the stock is 1.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.7.
Biofil Chemicals and Pharmaceuticals Limited's total revenue sank by 75.0% to $32M since the same quarter in the previous year.
Its net income has increased by 123.4% to $5M since the same quarter in the previous year.
Based on the above factors, Biofil Chemicals and Pharmaceuticals Limited gets an overall score of 2/5.
| CurrencyCode | INR |
|---|---|
| Exchange | NSE |
| ISIN | INE829A01014 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 783M |
|---|---|
| PE Ratio | 126.58 |
| Target Price | None |
| Beta | 2.02 |
| Dividend Yield | None |
Biofil Chemicals and Pharmaceuticals Limited manufactures and trades in pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic drippers and caps for packing applications. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Pharmaceuticals Limited was incorporated in 1985 and is based in Indore, India.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BIOFILCHEM.NSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
